[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.17.16. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 17, 1995

Pharmacologic Treatment of Congestive Heart Failure

Author Affiliations

Les Nouveaux Généralistes Liege, Belgium

JAMA. 1995;273(19):1492. doi:10.1001/jama.1995.03520430027028
Abstract

To the Editor.  —The Review by Dr Baker and colleagues1 regarding pharmacologic treatment of heart failure is interesting for general practitioners in Belgium. However, I was amazed to find the following recommendation in this article: "Fourth, hospitalize the patient and institute intravenous inotropic therapy such as intravenous dobutamine to increase renal blood flow and facilitate diuresis," but no mention for or against oral therapy with ibopamine. Several recent publications have spoken in favor of oral ibopamine use, even during angiotensin-converting enzyme inhibitor treatment.2-4

First Page Preview View Large
First page PDF preview
First page PDF preview
×